Literature DB >> 30733298

Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer.

Xuefei Li1, Tina Gruosso2,3, Dongmei Zuo2, Atilla Omeroglu4, Sarkis Meterissian3,5, Marie-Christine Guiot4,6, Adam Salazar1, Morag Park7,3,8, Herbert Levine9,10,11.   

Abstract

Infiltration of [Formula: see text] T lymphocytes into solid tumors is associated with good prognosis in various types of cancer, including triple-negative breast cancer (TNBC). However, the mechanisms underlying different infiltration levels are largely unknown. Here, we have characterized the spatial profile of [Formula: see text] T cells around tumor cell clusters (tightly connected tumor cells) in the core and margin regions in TNBC patient samples. We found that in some patients, the [Formula: see text] T cell density first decreases when moving in from the boundary of the tumor cell clusters and then rises again when approaching the center. To explain various infiltration profiles, we modeled the dynamics of T cell density via partial differential equations. We spatially modulated the diffusion/chemotactic coefficients of T cells (to mimic physical barriers) or introduced the localized secretion of a diffusing T cell chemorepellent. Combining the spatial-profile analysis and the modeling led to support for the second idea; i.e., there exists a possible chemorepellent inside tumor cell clusters, which prevents [Formula: see text] T cells from infiltrating into tumor cell clusters. This conclusion was consistent with an investigation into the properties of collagen fibers which suggested that variations in desmoplastic elements does not limit infiltration of [Formula: see text] T lymphocytes, as we did not observe significant correlations between the level of T cell infiltration and fiber properties. Our work provides evidence that [Formula: see text] T cells can cross typical fibrotic barriers and thus their infiltration into tumor clusters is governed by other mechanisms possibly involving a local repellent.

Entities:  

Keywords:  ECM; TIL; TNBC; chemokine; tumor-cell clusters

Mesh:

Year:  2019        PMID: 30733298      PMCID: PMC6397588          DOI: 10.1073/pnas.1817652116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.

Authors:  Padmanee Sharma; Yu Shen; Sijin Wen; Sachiko Yamada; Achim A Jungbluth; Sacha Gnjatic; Dean F Bajorin; Victor E Reuter; Harry Herr; Lloyd J Old; Eiichi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

2.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Authors:  Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine Ambrosone; James Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

3.  Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

Authors:  Sahar M A Mahmoud; Emma Claire Paish; Desmond G Powe; R Douglas Macmillan; Matthew J Grainge; Andrew H S Lee; Ian O Ellis; Andrew R Green
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Authors:  Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

5.  Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.

Authors:  Hélène Salmon; Katarzyna Franciszkiewicz; Diane Damotte; Marie-Caroline Dieu-Nosjean; Pierre Validire; Alain Trautmann; Fathia Mami-Chouaib; Emmanuel Donnadieu
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

6.  Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma.

Authors:  Elizabeth M E Verdegaal; Conny Hoogstraten; Maro H Sandel; Peter J K Kuppen; Antoinette A T P Brink; Frans H J Claas; Michael C B Gorsira; J Frans Graadt van Roggen; Susanne Osanto
Journal:  Cancer Immunol Immunother       Date:  2006-08-22       Impact factor: 6.968

7.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

8.  Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

Authors:  Sofia Lyford-Pike; Shiwen Peng; Geoffrey D Young; Janis M Taube; William H Westra; Belinda Akpeng; Tullia C Bruno; Jeremy D Richmon; Hao Wang; Justin A Bishop; Lieping Chen; Charles G Drake; Suzanne L Topalian; Drew M Pardoll; Sara I Pai
Journal:  Cancer Res       Date:  2013-01-03       Impact factor: 12.701

9.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Authors:  Franck Pagès; Amos Kirilovsky; Bernhard Mlecnik; Martin Asslaber; Marie Tosolini; Gabriela Bindea; Christine Lagorce; Philippe Wind; Florence Marliot; Patrick Bruneval; Kurt Zatloukal; Zlatko Trajanoski; Anne Berger; Wolf-Herman Fridman; Jérôme Galon
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

Review 10.  Tumour progression and the nature of cancer.

Authors:  W H Clark
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

View more
  34 in total

1.  Cross-Link-Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications.

Authors:  Zhuoran Ma; Feifei Wang; Yeteng Zhong; Felix Salazar; Jiachen Li; Mingxi Zhang; Fuqiang Ren; Anna M Wu; Hongjie Dai
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2020-07-17

2.  Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissues.

Authors:  Kathleen M Kokolus; Nataša Obermajer; Pawel Kalinski
Journal:  Methods Enzymol       Date:  2019-06-25       Impact factor: 1.600

3.  Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.

Authors:  Florence Gazeau; Emmanuel Donnadieu; Alba Nicolas-Boluda; Javier Vaquero; Lene Vimeux; Thomas Guilbert; Sarah Barrin; Chahrazade Kantari-Mimoun; Matteo Ponzo; Gilles Renault; Piotr Deptula; Katarzyna Pogoda; Robert Bucki; Ilaria Cascone; José Courty; Laura Fouassier
Journal:  Elife       Date:  2021-06-09       Impact factor: 8.140

4.  Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell death.

Authors:  Prathyusha Konda; John A Roque Iii; Liubov M Lifshits; Angelita Alcos; Eissa Azzam; Ge Shi; Colin G Cameron; Sherri A McFarland; Shashi Gujar
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 5.  GPNMB: a potent inducer of immunosuppression in cancer.

Authors:  Anna-Maria Lazaratos; Matthew G Annis; Peter M Siegel
Journal:  Oncogene       Date:  2022-09-01       Impact factor: 8.756

Review 6.  The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment.

Authors:  Bo Ma; Alan Wells; Amanda M Clark
Journal:  Semin Cancer Biol       Date:  2019-07-31       Impact factor: 15.707

Review 7.  Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment.

Authors:  Sarah Jenkins; Robert Wesolowski; Margaret E Gatti-Mays
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

Review 8.  Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge.

Authors:  Grace G Bushnell; Abhijeet P Deshmukh; Petra den Hollander; Ming Luo; Rama Soundararajan; Dongya Jia; Herbert Levine; Sendurai A Mani; Max S Wicha
Journal:  NPJ Breast Cancer       Date:  2021-05-28

9.  Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion.

Authors:  Sumiyo Saburi; Takahiro Tsujikawa; Aya Miyagawa-Hayashino; Junichi Mitsuda; Kanako Yoshimura; Alisa Kimura; Hiroki Morimoto; Gaku Ohmura; Akihito Arai; Hiroshi Ogi; Eiichi Konishi; Kyoko Itoh; Kiminori Sugino; Shigeru Hirano
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 7.842

Review 10.  The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.

Authors:  Huogang Wang; Mingo M H Yung; Hextan Y S Ngan; Karen K L Chan; David W Chan
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.